ARACHIDONIC ACID METABOLISM AND CANCER CHEMOPREVENTION
ARACHIDONIC ACID METABOLISM AND CANCER CHEMOPREVENTION
批准号:
3181173
负责人:
DAVID L. MCCORMICK
金额:
$18.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-30 至 1992-03-31
关键词:
arachidonate breast neoplasms cancer prevention carcinogenesis carcinogenesis inhibitor dietary lipid drug adverse effect eicosanoid metabolism enzyme inhibitors epithelium fatty acid biosynthesis laboratory rat leukotrienes linolenate lipoxygenase mammary gland molecular oncology neoplasm /cancer nutrition therapy nutrition related neoplasm /cancer nutrition related tag phospholipase A2 prostacyclins prostaglandin endoperoxide synthase thromboxanes unsaturated fatty acids
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Neoplastic development in the rat mammary gland is subject to
regulation by metabolites of arachidonic acid (eicosanoids).
Modifiers of several pathways of arachidonic acid metabolism are
effective inhibitors of mammary carcinogenesis, and eicosanoids
have been proposed as mediators of the enhancement of mammary
cancer induction by dietary fat. The research program described
in the present proposal seeks to define further the role of
eicosanoids in mammary carcinogenesis, with specific emphasis on
the modification of arachidonic acid metabolism as a mechanism for
mammary cancer chemoprevention. The overall objectives of the
proposed program are: (a) to identify specific pathways and
products of arachidonic acid metabolism which can regulate
neoplastic development in the rat mammary gland; (b) to study the
role of eicosanoids as mediators of dietary fat action in the
mammary epithelium; and (c) on the basis of the results of these
studies, to develop mammary cancer chemoprevention regimens with
efficacy to toxicity ratios superior to those presently available.
A combined in vitro/in vivo approach will be used to address these
issues. In order to define regimens with maximal activity in sup-
pressing specific pathways of arachidonic acid metabolism, studies
will be conducted to determine the influence of pharmacologic
agents on eicosanoid biosynthesis in primary cultures of rat
mammary epithelial cells. These experiments will also address
possible limitations to anticarcinogenic efficacy as a result of
redirection of arachidonic acid metabolism. Additional studies
will investigate the influence of fatty acids on eicosanoid
biosynthesis, and the effects of modifiers of arachidonic acid
metabolism on fatty acid action. These in vitro results will then
be integrated into the design of protocols for in vivo
carcinogenesis experiments, with the goals of: (a) developing non-
toxic chemoprevention regimens with increased anticarcinogenic
activity; (b) defining the interactions among various pathways of
arachidonic acid metabolism in the modulation of mammary cancer
induction; and (c) determining the possible role of eicosanoid
biosynthesis in the mechanism of dietary fat action in mammary
carcinogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical development of myosolvins, a new class of medicine for asthma
-
批准号:8757703
-
项目类别:
-
资助金额:$176.14万
-
财政年份:2014
-
负责人:DAVID L. MCCORMICK
-
依托单位:
Preclinical development of myosolvins, a new class of medicine for asthma
-
批准号:9334925
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:DAVID L. MCCORMICK
-
依托单位:
Therapeutic Targeting of Carotid Body Chemoreflex for Sleep Disordered Breathing
-
批准号:8753684
-
项目类别:
-
资助金额:$166.37万
-
财政年份:2014
-
负责人:DAVID L. MCCORMICK
-
依托单位:
'IN VITRO SCREENING OF SELECTED CHEMOPREVENTIVE AGENTS U
-
批准号:6314984
-
项目类别:
-
资助金额:$24.72万
-
财政年份:2000
-
负责人:DAVID L. MCCORMICK
-
依托单位:
AN ORAL CARCINOGENICITY STUDY IN P53 (+/-) MICE - (TASK
-
批准号:6356129
-
项目类别:
-
资助金额:$32.87万
-
财政年份:2000
-
负责人:DAVID L. MCCORMICK
-
依托单位:
RANGE FINDING/ACUTE ORAL TOXICITY OF CHEMOPREVENTIVES
-
批准号:6356126
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2000
-
负责人:DAVID L. MCCORMICK
-
依托单位:
EFFICACY STUDIES OF CHEMOPREVENTIVE AGENTS IN ANIMAL MOD
-
批准号:6346797
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2000
-
负责人:DAVID L. MCCORMICK
-
依托单位:
PRECLINICAL TOXICOLOGY - SEGMENT II TERATOLOGY STUDIES O
-
批准号:6153043
-
项目类别:
-
资助金额:$88.85万
-
财政年份:1999
-
负责人:DAVID L. MCCORMICK
-
依托单位:
PRECLINICAL TOXICOLOGY (WS#52) -CHRONIC ORAL TOXICITY S
-
批准号:6156853
-
项目类别:
-
资助金额:$32.66万
-
财政年份:1999
-
负责人:DAVID L. MCCORMICK
-
依托单位:
PRECLINICAL TOXICOLOGY - SEGMENT II TERATOLOGY STUDIES O
-
批准号:6212358
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:DAVID L. MCCORMICK
-
依托单位:
PRECLINICAL TOXICOLOGY (WS#52) -CHRONIC ORAL TOXICITY S
-
批准号:6212359
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:DAVID L. MCCORMICK
-
依托单位:
EFFICACY STUDIES OF CHEMOPREVENTIVE AGENTS
-
批准号:6131187
-
项目类别:
-
资助金额:$65.98万
-
财政年份:1999
-
负责人:DAVID L. MCCORMICK
-
依托单位:
PRECLINICAL TOXICOLOGY (WS#52) -CHRONIC ORAL TOXICITY S
-
批准号:6356787
-
项目类别:
-
资助金额:$3.7万
-
财政年份:1999
-
负责人:DAVID L. MCCORMICK
-
依托单位:
CHEMOPREVENTION WITH RODENT MODELS OF HEAD & NECK TUMORS
-
批准号:6382885
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:DAVID L. MCCORMICK
-
依托单位:
PRECLINICAL TOXICOLOGY & PHARMACOLOGY OF DRUGS DEVELOPED
-
批准号:2854366
-
项目类别:
-
资助金额:$15.0万
-
财政年份:1998
-
负责人:DAVID L. MCCORMICK
-
依托单位:
CHEMOPREVENTION OF N-BUTYL-N(4-HYDROXYBUTYL)-NITROSAMINI
-
批准号:2879442
-
项目类别:
-
资助金额:$31.0万
-
财政年份:1998
-
负责人:DAVID L. MCCORMICK
-
依托单位:
CHEMOPREVENTIVE AGENT EFFICACY USING CHEMICALLY INDUCED
-
批准号:6194222
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:DAVID L. MCCORMICK
-
依托单位:
PRECLINICAL TOXICOLOGY & PHARMACOLOGY OF DRUGS DEVELOPED
-
批准号:6352294
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1998
-
负责人:DAVID L. MCCORMICK
-
依托单位:
PRECLINICAL TOXICOLOGY & PHARMACOLOGY OF DRUGS DEVELOPED
-
批准号:6324308
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:DAVID L. MCCORMICK
-
依托单位:
PRECLINICAL TOXICOLOGY & PHARMACOLOGY OF DRUGS DEVELOPED
-
批准号:2719876
-
项目类别:
-
资助金额:$39.51万
-
财政年份:1998
-
负责人:DAVID L. MCCORMICK
-
依托单位:
海外基金